BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/20/2020 4:04:17 AM | Browse: 22 | Download: 36
Publication Name World Journal of Gastroenterology
Manuscript ID 55958
Country/Territory United Arab Emirates
Received
2020-04-16 14:03
Peer-Review Started
2020-04-16 14:03
To Make the First Decision
Return for Revision
2020-05-01 02:46
Revised
2020-07-15 16:35
Second Decision
2020-10-10 10:04
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-10-13 05:15
Articles in Press
2020-10-13 05:15
Publication Fee Transferred
Edit the Manuscript by Language Editor
2020-10-25 18:49
Typeset the Manuscript
2020-11-18 01:32
Publish the Manuscript Online
2020-11-20 04:04
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Expert Consensus
Article Title First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus
Manuscript Source Invited Manuscript
All Author List Maryam Alkhatry, Ahmad Al-Rifai, Vito Annese, Filippos Georgopoulos, Ahmad N Jazzar, Ahmed M Khassouan, Zaher Koutoubi, Rahul Nathwani, Mazen S Taha and Jimmy K Limdi
ORCID
Author(s) ORCID Number
Maryam Alkhatry http://orcid.org/0000-0002-1427-7831
Ahmad Al-Rifai http://orcid.org/0000-0003-1710-7114
Vito Annese http://orcid.org/0000-0002-0082-892X
Filippos Georgopoulos http://orcid.org/0000-0003-0634-4026
Ahmad N Jazzar http://orcid.org/0000-0002-4555-7067
Ahmed M Khassouan http://orcid.org/0000-0001-8738-9490
Zaher Koutoubi http://orcid.org/0000-0001-7894-9900
Rahul Nathwani http://orcid.org/0000-0001-0080-891P
Mazen S Taha http://orcid.org/0000-0002-2264-8559
Jimmy K Limdi http://orcid.org/0000-0002-1039-6251
Funding Agency and Grant Number
Funding Agency Grant Number
Emirates Gastroenterology and Hepatology Society 001802
Corresponding Author Vito Annese, MD, PhD, Assistant Professor, Director, Department of Gastroenterolog, Valiant Clinic, City Walk 13th Street, Dubai N/A, United Arab Emirates. vitoannese1@gmail.com
Key Words Ulcerative colitis; Crohn’s disease; Infliximab; Adalimumab; Vedolizumab; Ustekinumab
Core Tip Prevalence of ulcerative colitis and Crohn’s disease is on rise worldwide including Middle East. The progressive advance in our understanding of the etiopathogenesis coupled with an unprecedented increase in therapeutic options have progressive changed the management towards to a tailoring evidence-based intervention. In the consensus, statements have been agreed about the diagnosis of inflammatory bowel diseases based on the clinical evaluation and a combination of endoscopic, histological, radiological, and/or biochemical findings. In addition, the therapeutic options including biological and “small molecule” therapies have been revised in view of the treatment goals, which now aim to treat beyond “symptoms”, to achieve mucosal healing when possible and to minimise intestinal injury and bowel damage with resultant disability.
Publish Date 2020-11-20 04:04
Citation Alkhatry M, Al-Rifai A, Annese V, Georgopoulos F, Jazzar AN, Khassouan AM, Koutoubi Z, Nathwani R, Taha MS, Limdi JK. First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus. World J Gastroenterol 2020; 26(43): 6710-6769
Url https://www.wjgnet.com/1007-9327/full/v26/i43/6710.htm
DOI https://dx.doi.org/10.3748/wjg.v26.i43.6710
Full Article (PDF) WJG-26-6710.pdf
Full Article (Word) WJG-26-6710.docx
Manuscript File 55958-Review-Filipodia.docx
Answering Reviewers 55958-Answering reviewers.pdf
Audio Core Tip 55958-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 55958-Conflict-of-interest statement.pdf
Copyright License Agreement 55958-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 55958-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate 55958-Language certificate.pdf
Supplementary Material 55958-Supplementary material.pdf
Peer-review Report 55958-Peer-review(s).pdf
Scientific Misconduct Check 55958-Bing-Yan JP-1.png
Scientific Misconduct Check 55958-Bing-Liu M-2.png
Scientific Misconduct Check 55958-Scientific misconduct check.pdf
Scientific Editor Work List 55958-Scientific editor work list.pdf